Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Anny Shai

Title(s)Clinical Research Analyst 4, Neurological Surgery
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020 Feb 06. PMID: 32027343.
      View in: PubMed
    2. Michael Zhang, Stephanie Hilz, Michael Martin, Chibo Hong, Yao Yu, Saumya Bollam, Matthew Grimmer, Timothy Looney, Geoffrey Lowman, Gauri Ganpule, Joanna Phillips, Anny Shai, Susan Chang, Jennifer Clarke, Jennie Taylor, Nicholas Butowski, Nancy Ann Oberheim-Bush, Mitchel Berger, Manish Aghi, Shawn Hervey-Jumper, Mike McDermott, Philip Theodosopoulos, Hideho Okada, Joseph Costello. IMMU-11. SPATIOTEMPORAL IMMUNOGENOMIC ANALYSIS OF THE T-CELL REPERTOIRE IN IDH-MUTANT LOWER GRADE GLIOMAS. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi121-vi121.
      View in: Publisher Site
    3. Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, Raleigh DR, Shai A, Phillips JJ, Bollen AW, Tihan T, Perry A, Costello J, Solomon DA. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol. 2019 05; 137(5):851-854. PMID: 30877433.
      View in: PubMed
    4. Annette Molinaro, Shawn Hervey-Jumper, Seunggu J. Han, Ramin Morshed, Marisa Lafontaine, Nicole Ebrahimi, Jacob Young, Joanna J Phillips, Anny Shai, Gayathri Warrier, Terri Rice, Yi Lin, Jason Crane, Sarah Nelson, Margaret Wrensch, John Wiencke, Arie Perry, Nancy Ann Oberheim Bush, Jennie Taylor, Nicholas Butowski, Michael Prados, Jennifer Clarke, Susan Chang, Edward Chang, Manish Aghi, Philip Theodosopoulos, Michael McDermott, Mitchel Berger. SURG-02. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology. 2018 Nov 5; 20(suppl_6):vi250-vi250.
      View in: Publisher Site
    5. Yao Yu, Stephanie Hilz, Matthew Grimmer, David Solomon, Serah Choi, Michael Wahl, Tali Mazor, Chibo Hong, Anny Shai, Joanna J Phillips, Javier Villanueva-Meyer, Michael McDermott, Daphne Haas-Kogan, Jennie Taylor, Nicholas Butowski, Jennifer Clarke, Mitchel Berger, Annette Molinaro, Susan Chang, Joseph Costello, Nancy Ann Oberheim Bush. PATH-29. CLINICAL SIGNIFICANCE OF TEMOZOLOMIDE-INDUCED SOMATIC HYPERMUTATION IN INITIALLY LOW-GRADE IDH-MUTANT DIFFUSE GLIOMAS. Neuro-Oncology. 2018 Nov 5; 20(suppl_6):vi164-vi165.
      View in: Publisher Site
    6. Prasanna Parvathaneni, Joanna Phillips, Juan R Cabrera, Anny Shai, Soonmee Cha, Susan Chang, Sarah Nelson, Janine Lupo. NIMG-43. APPLICATION OF AN ADVANCED DIFFUSION-WEIGHTED MRI TECHNIQUE TO CHARACTERIZE GLIOMA MICROSTRUCTURE AND RELATIONSHIP TO HISTOPATHOLOGY. Neuro-Oncology. 2016 Nov 1; 18(suppl_6):vi134-vi134.
      View in: Publisher Site
    7. Shai A, Dankort D, Juan J, Green S, McMahon M. TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Res. 2015 Aug 01; 75(15):3167-80. PMID: 26001956.
      View in: PubMed
    8. Shai A, Pitot HC, Lambert PF. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res. 2010 Jun 15; 70(12):5064-73. PMID: 20530688.
      View in: PubMed
    9. Maufort JP, Shai A, Pitot HC, Lambert PF. A role for HPV16 E5 in cervical carcinogenesis. Cancer Res. 2010 Apr 01; 70(7):2924-31. PMID: 20332225.
      View in: PubMed
    10. Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009 Sep 15; 23(18):2152-65. PMID: 19759263.
      View in: PubMed
    11. Chung SH, Wiedmeyer K, Shai A, Korach KS, Lambert PF. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. Cancer Res. 2008 Dec 01; 68(23):9928-34. PMID: 19047174.
      View in: PubMed
    12. Shai A, Pitot HC, Lambert PF. p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers. Cancer Res. 2008 Apr 15; 68(8):2622-31. PMID: 18413729.
      View in: PubMed
    13. Shai A, Brake T, Somoza C, Lambert PF. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res. 2007 Feb 15; 67(4):1626-35. PMID: 17308103.
      View in: PubMed